Section 16-42-22-8 - Requirements for substitution(a) For substitution to occur for a prescription other than a prescription filled under the Medicaid program (42 U.S.C. 1396 et seq.), the children's health insurance program established under IC 12-17.6-2, the biosimilar biological products requirements under IC 16-42-25, or the Medicare program (42 U.S.C. 1395 et seq.): (1) the practitioner must: (A) sign on the line under which the words "May substitute" appear; or(B) for an electronically transmitted prescription, electronically transmit the instruction "May substitute."; and(2) the pharmacist must inform the customer of the substitution.(b) This section does not authorize any substitution other than substitution of a generically equivalent drug product.Pre-1993 Recodification Citation: 16-6-8.1-2(c).
Amended by P.L. 96-2014, SEC. 5, eff. 7/1/2014.As added by P.L. 2-1993, SEC.25. Amended by P.L. 239-1999, SEC.7; P.L. 291-2001, SEC.233; P.L. 204-2005, SEC.10.